Skip to content

FDA 510(k) Clearance Consulting for Medical Device Companies


Streamline your FDA 510(k) submission process with expert guidance to ensure regulatory compliance and a smooth path to market clearance.

You need clearance from the US FDA to legally sell a medical device in the United States. To be considered for FDA clearance, most moderate-risk Class II devices (as well as some Class I and Class III devices) must submit a Pre-Market Notification, commonly referred to as a 510(k).

The 510(k) is a dossier of information about your device, similar to a Technical Documentation File in Europe. The basis of a 510(k) is to present a body of evidence that your device is substantially equivalent to a device already cleared for sale in the US, called a predicate. While this might position you to leverage existing data about your device, you must be meticulous when proving your device’s equivalence to its predicate.  

A thorough 510(k) is the key to a timely and positive decision from the FDA. Compiling a 510(k) requires substantial resources and preparation, not to mention deep knowledge of the regulatory, testing, clinical data requirements, and FDA published guidances that apply to your device. Expertise and experience can make all the difference when you get to this stage of your go-to-market plan.  

MedEnvoy brings decades of experience working directly with the FDA and preparing 510(k) submissions, which allows us to anticipate the type of information the FDA wants to see about your device. From initial strategy development to the final submission, we offer end-to-end support throughout the FDA 510(k) process.

We identify the regulatory, testing, and clinical data requirements for your device, appropriate submission type, and assist you in developing a robust plan tailored to your device and market goals.

We compile all necessary documentation for your 510(k) submission. We ensure that your submission meets the highest standards of clarity, completeness, and compliance.

Our consultants will perform a comprehensive classification assessment and identify a predicate device that is substantially equivalent to your device and aligns with our regulatory strategy.

We guide you through the intricacies of clinical data management, ensuring your clinical evidence supports your submission.

Our Regulatory Team Leaders


Dr. Jaap Laufer

Dr. Jaap Laufer

Director Swiss Office

CH Office


LinkedIn

Daryl Wisdahl

Director Consulting Services 

US Office


LinkedIn
Rocio Fallas

Rocio Fallas

Senior Regulatory Affairs Consultant

Latin American Office


LinkedIn
Jasmine Hall

Jasmine Hall

Senior Regulatory Affairs Consultant

US Office


LinkedIn
Cecilia Su

Cecilia Su

Senior Regulatory Affairs Consultant

US Office


LinkedIn
Brittany Dunning

Brittany Dunning

Regulatory Affairs Consultant

US Office


LinkedIn
Dean Adair

Dean Adair

Regulatory Affairs Consultant

EU Office


LinkedIn
Staci Dennis

Staci Dennis

Senior Regulatory Affairs Project Manager

US Office

Darlene Altman

Darlene Altman

Regulatory Affairs Project Manager

US Office


LinkedIn
Ally Gonzalez

Ally Gonzalez

Regulatory Affairs Project Manager

US Office


LinkedIn